You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Effect of Aripiprazole on Verbal Memory and Fluency in Schizophrenic Patients
|
---|---|
Published in |
CNS Drugs, September 2012
|
DOI | 10.1007/s40263-012-0003-4 |
Pubmed ID | |
Authors |
Chris Bervoets, Manuel Morrens, Kristof Vansteelandt, Frank Kok, Annick de Patoul, Veronique Halkin, Didier Pitsi, Eric Constant, Joseph Peuskens, Bernard Sabbe |
Abstract |
Second-generation antipsychotics have gradually replaced first-generation antipsychotics as first-line treatment for patients with schizophrenia. Some positive effects on verbal cognition have been shown for the second-generation antipsychotics, but most studies are based on relatively small numbers of patients. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 87 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | 1% |
Unknown | 86 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 14 | 16% |
Researcher | 11 | 13% |
Student > Doctoral Student | 10 | 11% |
Student > Master | 9 | 10% |
Other | 8 | 9% |
Other | 16 | 18% |
Unknown | 19 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Psychology | 19 | 22% |
Medicine and Dentistry | 18 | 21% |
Agricultural and Biological Sciences | 6 | 7% |
Neuroscience | 5 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
Other | 10 | 11% |
Unknown | 26 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 November 2014.
All research outputs
#20,243,777
of 22,771,140 outputs
Outputs from CNS Drugs
#1,222
of 1,305 outputs
Outputs of similar age
#152,198
of 171,032 outputs
Outputs of similar age from CNS Drugs
#47
of 49 outputs
Altmetric has tracked 22,771,140 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,305 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.2. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 171,032 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.